Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
DCPH was delisted on the 10th of June, 2024.
167 hedge funds and large institutions have $1.94B invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 59 increasing their positions, 56 reducing their positions, and 38 closing their positions.
61% more call options, than puts
Call options by funds: $13.7M | Put options by funds: $8.54M
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
5% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 56
8% less funds holding
Funds holding: 182 → 167 (-15)
21% less capital invested
Capital invested by funds: $2.47B → $1.94B (-$527M)
39% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$23.7M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$22.7M |
| 3 |
BNP Paribas Asset Management
Paris,
France
|
+$17.7M |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$15.7M |
| 5 |
O
OrbiMed
New York
|
+$11.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$30.2M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$27.9M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$19.5M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$18.9M |
| 5 |
AG
Artal Group
Luxembourg
|
-$14M |
DCPH Hedge Fund Activity: Q1 2021 in Review
167 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q1 2021, worth a combined $1.94B — down 21% from $2.47B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of DCPH and 23 opened new positions — a net loss of 15 holders — while 56 trimmed existing stakes and 59 added.
The largest buyer was Consonance Capital Management, adding an estimated $23.7M. The largest seller was Fidelity Investments, cutting an estimated $30.2M.
- 167 institutional investors held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q1 2021, down from 182 in Q4 2020.
- Funds reported $1.94B of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q1 2021, down 21% quarter-over-quarter.
- 23 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q1 2021 and 38 closed out, a net change of -15 holders.
- The largest Deciphera Pharmaceuticals, Inc. Common Stock buyer in Q1 2021 was Consonance Capital Management, an estimated $23.7M added.
- The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q1 2021 was Fidelity Investments, an estimated $30.2M sold.
Based on aggregated 13F filings for Q1 2021.